Oral phenylephrine is sold as a nasal decongestant. It doesn't work very well, and the U.S. Food and Drug administration ...

Sudafed, Mucinex, Benadryl, Advil, Tylenol, Vicks, and Dimetapp. These popular brand names appear on oral decongestants that ...

COPD management typically involves medications like bronchodilators, which ease breathing by relaxing ... FEV1 increasing by ...

The committee “unanimously concluded that the current scientific data do not support that the recommended dosage in the OTC cold, cough, allergy, bronchodilator and antiasthmatic drug products ...

In the D-A-CH region, the projected revenue in the Bronchodilator Drugs market is expected to reach US$1.44bn by 2024. It is anticipated that the revenue will exhibit an annual growth rate (CAGR ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...

When you purchase something in a pharmacy to help you with sleep, allergies or another minor ailment, you’ll inevitably see ...

The FDA announced on Thursday a proposed order to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) ...

Cholinergic drugs (acetylcholine and methacholine ... Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history ...

Trials using oral dosing of labeled and unlabeled drug have demonstrated that the ... Patients included those inadequately controlled with bronchodilators alone (Trial 1), those already receiving ...

The company's current product candidate and potential value creator is ensifentrine (commercially "Ohtuvayre"), an inhaled ...

Increased risk of serotonin syndrome with serotonergic drugs (eg, SSRIs ... of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.